Skip to content
Clinical Research Made Simple

Clinical Research Made Simple

Trusted Resource for Clinical Trials, Protocols & Progress

Tag: causality assessment CDSCO

Compensation Rules for Clinical Trial Injury under CDSCO: A Detailed Guide

Posted on May 15, 2025 digi By digi

Compensation Rules for Clinical Trial Injury under CDSCO: A Detailed Guide Understanding CDSCO’s Compensation Rules for Clinical Trial Injuries in India India’s clinical research environment has evolved with an emphasis on ethical conduct and subject safety. One significant development was the implementation of compensation rules for clinical trial-related injuries under the Central Drugs Standard Control…

Read More “Compensation Rules for Clinical Trial Injury under CDSCO: A Detailed Guide” »

CDSCO (India) Guidelines, Regulatory Guidelines

Quick Guide

  • Clinical Trial Phases
    • Preclinical Studies
    • Phase 0 (Microdosing Studies)
    • Phase 1 (Safety and Dosage)
    • Phase 2 (Efficacy and Side Effects)
    • Phase 3 (Confirmation and Monitoring)
    • Phase 4 (Post-Marketing Surveillance)
  • Regulatory Guidelines
    • U.S. FDA Regulations
    • CDSCO (India) Guidelines
    • EMA (European Medicines Agency) Guidelines
    • PMDA (Japan) Guidelines
    • MHRA (UK) Guidelines
    • TGA (Australia) Guidelines
    • Health Canada Guidelines
    • WHO Guidelines
    • ICH Guidelines
    • ASEAN Guidelines
  • Clinical Trial Design and Protocol Development
    • Randomized Controlled Trials (RCTs)
    • Adaptive Trial Designs
    • Crossover Trials
    • Parallel Group Designs
    • Factorial Designs
    • Cluster Randomized Trials
    • Single-Arm Trials
    • Open-Label Studies
    • Blinded Studies (Single, Double, Triple)
    • Non-Inferiority and Equivalence Trials
    • Randomization Techniques in Crossover Trials
  • Good Clinical Practice (GCP) and Compliance
    • GCP Training Programs
    • ICH-GCP Compliance
    • GCP Violations and Audit Responses
    • Monitoring Plans
    • Investigator Responsibilities
    • Sponsor Responsibilities
    • Ethics Committee Roles

Menu

Recent Posts

  • Incorporating PROs and QoL Data in Phase 4 Clinical Trials
  • Evaluating Drug Efficacy Using Parallel Methodology – Clinical Trial Design and Protocol Development
  • Phase 1 Studies for Inhaled Therapies: PK, PD, and Device Considerations
  • How to Prepare for GCP Inspections During Ongoing Phase 3 Trials: Compliance, Readiness, and Best Practices
  • Blinding and Randomization in Parallel Designs – Clinical Trial Design and Protocol Development

Copyright © 2025 Clinical Research Made Simple.

Powered by PressBook WordPress theme